Organogenesis Holdings (ORGO) Capital Leases (2017 - 2026)
Organogenesis Holdings (ORGO) posted quarterly Capital Leases of $12.4 million for Q1 2026, up 2906.81% year-over-year from $411000.0 in Q1 2025, and down 3.36% quarter-over-quarter from $12.8 million in Q4 2025.
Organogenesis Holdings (ORGO) Capital Leases (2017 - 2026) Analysis & Trends
Organogenesis Holdings' Capital Leases history runs 9 years deep, the most recent figure standing at $12.4 million for Q1 2026.
- In Q1 2026, Capital Leases rose 2906.81% year-over-year to $12.4 million; the TTM figure through Mar 2026 stood at $12.4 million (up 2906.81% YoY), while the FY2025 annual figure was $12.8 million, up 1681.06% from the prior year.
- Capital Leases for Q1 2026 stood at $12.4 million, down from $12.8 million in the prior quarter.
- The five-year high for Capital Leases was $12.8 million in Q4 2025, with the low at $98000.0 in Q2 2025.
- The 4-year median for Capital Leases is $1.5 million (2024), against an average of $3.1 million.
- The sharpest annual moves came in 2025 and 2026: Capital Leases tumbled 92.54% in 2025, then soared 2906.81% in 2026.
- Organogenesis Holdings' Capital Leases stood at $1.9 million in 2023, then plunged by 61.97% to $718000.0 in 2024, then soared by 1681.06% to $12.8 million in 2025, then retreated by 3.36% to $12.4 million in 2026.
- Business Quant data shows ORGO's Capital Leases at $12.4 million in Q1 2026, $12.8 million in Q4 2025, and $2.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Organogenesis Holdings | 238.69 Mn | 191.85 Mn | 20.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.82 Mn |
| Mar 31, 2026 | 12.36 Mn |
| Dec 31, 2025 | 12.79 Mn |
| Sep 30, 2025 | 2.09 Mn |
| Jun 30, 2025 | 98,000.00 |
| Mar 31, 2025 | 411,000.00 |
| Dec 31, 2024 | 718,000.00 |
| Sep 30, 2024 | 1.02 Mn |
| Jun 30, 2024 | 1.31 Mn |
| Mar 31, 2024 | 1.60 Mn |
| Dec 31, 2023 | 1.89 Mn |
| Sep 30, 2023 | 2.17 Mn |
| Jun 30, 2023 | 402,000.00 |
| Sep 30, 2021 | 831,000.00 |
| Jun 30, 2021 | 9.55 Mn |
| Mar 31, 2021 | 10.52 Mn |
| Dec 31, 2020 | 11.44 Mn |
| Sep 30, 2020 | 12.24 Mn |
| Jun 30, 2020 | 13.01 Mn |
| Mar 31, 2020 | 13.76 Mn |